SureTrader Advertisement SureTrader
Home > Boards > US OTC > Biotechs >

Health Discovery Corporation (HDVY)

HDVY RSS Feed
Add HDVY Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 4/3/2016 7:13:43 PM - Followers: 95 - Board type: Free - Posts Today: 0

 

 HDVY information: (check the stickies for the latest information)

HDVY 12/10/10 Share structure: 

O/S  247,350,747
A/S 300,000,000

Health Discovery Corporation
2 East Bryan Street, Suite 601
Savannah, Georgia 31401

Phone: 912.443.1987
912.443.1988
Fax: 912.443.1989

investor@healthdiscoverycorp.com

 

Updates:


2/11/2011 Form 10-Q/A      http://yahoo.brand.edgar-online.com/DisplayFiling.aspx?dcn=0001188112-11-000245

1/05/2011  Form 8-K

12/30/2010  Form 8-K 

12/10/10 Securities Registration Statement (S-1) 

11/15/2010: Latest 10-Q released

11/2/2010: Health Discovery Corp. awarded a $244,479.25 Qualifying Therapeutic Discovery Project (QTDP) Grant

To view all SEC filings please visit   http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001141788&owner=include 

To view the Shareholder Letter from Dr. Barnhill, dated 8/26/2010:  http://www.healthdiscoverycorp.com/pr.php#

5/16/10: Health Discovery Corporation Receives Prestigious MICO Award from MDB Capital Group LLC (click on the link above and see the item dated Feb. 26, 2010)

1/28/2010: HIGHEST VOLUME IN HISTORY. OVER 10 MILLION SHARES

10/20/2009: New 5 year high

 A link to all PR's is found on the company website some are linked below!!

http://healthdiscoverycorp.com/pr.php#

 

Tom Gallagher added to the team Ex Goldman VP seems to have a credential or two!!!

http://healthdiscoverycorp.com/pr/nov30_09.html 11/30/2009

47Patents held by HDVY!! 47 and 34 more pending!!!!

http://www.healthdiscoverycorp.com/intellectual.html 06/21/2010

Global PR firm hired to represent HDVY only the best!!!

http://healthdiscoverycorp.com/pr/oct09_09.html  10/9/2009

 

 What does it mean when the Ex FDA Commissioner is signed for a 4 month contract and your about launch a Prostate test with Quest and Abbott? $$$$

http://healthdiscoverycorp.com/pr/sep18_09.html 09/18/2009

Peer review published in UroToday Journal of Medicine highlighting HDVY's Prostate test 7/14/2009

http://healthdiscoverycorp.com/pr/july14_09.html

 

Deal with Quest :  http://www.healthdiscoverycorp.com/pr/feb5b_09.html  2/5/2009
Deal with Abbott : http://www.healthdiscoverycorp.com/pr/feb5a_09.html 2/5/2009

Prostate tissue test launch HDC to recieve 30% of all proceeds. Hints at more tests soon and hires firm to monetize IP portfolio. 8/7/2008

 From the CEO of IPotential a leading IP Patent law firm. Google IPotential and see the huge list of household name clients they have represented. Now see what the CEO says about HDVY!!"We are pleased to initiate our relationship with such a unique innovator like Health Discovery Corporation," said Ron Epstein, CEO of IPotential. "HDC's seminal SVM patents have broad applicability wherever large amounts of complex data must be manipulated mathematically. SVM technology will play a critical role in the development of the next generation of Internet search and anti-spam as well as a broad array of artificial intelligence products. We know that SVMs using HDC's patented technologies are broadly deployed across many markets and we look forward to working with the company in both publicizing and protecting its valuable IP."


_________________________________________________________________


ALL PRESS RELEASES ARE ON THE HDC WEBSITE
Tons of info and software examples on the HDC website.
http://www.healthdiscoverycorp.com/#



_________________________________________________________________




HDVY's website with PR's, Bios, Updates, read up and do your own DD, but the people involved are top notch. There is no toxic dilution, the CEO took  a pay cut to stave off dilution at one point in time, these are very wealthy people involved here with real reputations to protect. They have already made their money they are not here to line their pockets, but to build a legacy and  R&D  with partner with other Pharms/Biotechs for better solutions save lives.  

 http://www.healthdiscoverycorp.com/

 

"Major Partnerships w/ Pfizer (NYSE), Abbott (NYSE), Quest Diagnostics (NYSE), CLRT (NASD), IART (NASD), BRKR (NASD) . These FORTUNE 500 companies have to pay royalty fees forever to these HDVY since HDVY licenses their SVM-RFE Technology to them and this company is not even $1.00. VRLMQ went from .06 to almost $20/share on the approval of the OVA (Ovarian Test) using the technology licensed to them by HDVY. Demonstrates how undervalued HDVY is at .38.

HDC’s License Partners (From 10/19/09 PR)

HDC’s key license partners to date include Abbott Laboratories (NYSE: ABT - News), Quest Diagnostics (NYSE: DGX - News), Clarient Inc. (Nasdaq: CLRT - News) and Pfizer Inc. (NYSE: PFE - News).
HDC recently entered into royalty-bearing licenses for its new urine-based prostate cancer test with Quest Diagnostics Incorporated and Abbott Laboratories for development and commercialization. These licenses are solely for the use of HDC’s prostate cancer biomarkers in urine.
HDC also entered into royalty-bearing licenses for its tissue biopsy-based prostate cancer test with Abbott Laboratories and Clarient Inc. for development and commercialization. This license is solely for the use of HDC’s prostate cancer biomarkers in tissue biopsy specimens.
HDC has also partnered with Pfizer Inc. for use of HDC’s SVM and SVM-RFE pattern recognition technology in Pfizer’s global research and development.
HDC has also entered into a license with Smart Personalized Medicine, LLC (“SPM”), a privately-held company, founded by Dr. Richard Caruso, Chairman and founder of Integra Life Sciences (NasdaqGS: IART - News) to develop a superior breast cancer prognostic test using HDC’s SVM technology in cooperation with MD Anderson Cancer Center. HDC has a fifteen percent equity position in SPM and HDC will receive royalties from this new breast cancer prognostic test.
HDC has entered into a development and license agreement with DCL Medical Laboratories, LLC, for the collaborative development and commercialization of SVM-based computer assisted diagnostic tests for the independent detection of ovarian, cervical and endometrial cancers.
HDC’s Patents Cover Non-Medical Applications
There are a large number of non-medical applications protected by HDC’s patents, including but not limited to, fraud detection, investment and commodities price predictions, bankruptcy prediction, image and object analysis, face recognition, text and document classification, speech recognition, personalized consumer purchasing patterns, decryption, vehicle control and monitoring, weather forecasting and database marketing.
Total Number of Patents Pending and Issued
With the issuance of the new patents described above, HDC now holds exclusive rights to a total of 37 issued U.S. and foreign patents. There will be 41 when the 4 new ones (subjects of the Notices of Allowance) issue in the next few months. HDC has a total of 71 patents pending and issued. Importantly, the first expiration of any of the HDC patents is May 2019 and new patents are currently being filed which when granted will have an additional 20 years of protection for the Company.
HDC’s Successful Prosecution of Patent Infringement Cases
In addition to the Vermillion patent infringement case described above, HDC successfully prosecuted a patent infringement lawsuit against Equbits LLC, which resulted in a permanent injunction against Equbits, LLC.
“HDC is determined to continue to grow and protect its valuable intellectual property portfolio. The Equbits judgment and Vermillion settlement and limited license strengthens our licensing posture in the marketplace and sets the appropriate tone for our future enforcement efforts,” stated Stephen D. Barnhill, M.D., HDC’s Chairman and CEO.
“HDC remains firmly committed to successfully monetizing our valuable intellectual property through additional licensing, close collaboration, development and commercialization with our business partners and we will also continue to protect our patent portfolio through robust enforcement action when strategically appropriate," said Dr. Barnhill.
HDC’s patent strategy includes a significant after-claiming component with multiple CIP’s and Continuations already in place. 




HDC has the only issued patents in the world for the SVM-RFE technology, which was discovered by members of the HDC science team. The SVM-RFE technology was the method used to discover the Company’s new tissue and urine based prostate cancer tests recently licensed to Quest Diagnostics (NYSE: DGX - News), Abbott Laboratories (NYSE: ABT - News) and Clarient Inc. (Nasdaq: CLRT - News).


Kary B. Mullis won the Nobel Prize in Chemistry in 1993
Kary Mullis Ph.D. is a Biochemist who got the 1993 Nobel prize for his invention of the Polymerase Chain Reaction, a technique used in AIDS tests
http://www.virusmyth.com/aids/index/kmullis.htm


Former Deputy FDA Commissioner John Norris Appointed Chief OperatingOfficer at Health Discovery Corporation.
http://www.allbusiness.com/medicine-health/diagnostics-screening-testing/13114880-1.html
Health Discovery Corporation (OTCBB:HDVY), a personalized medicinecompany specializing in molecular diagnostics including gene-based testing, as well as computer assisted diagnostics in digital pathologyand radiology, announced that former Deputy FDA Commissioner John A.Norris has been appointed as Chief Operating Officer (COO) of the Company. He will be responsible for business development, primarily creating new strategic partnerships, licenses and contracts to complement the Company's existing agreements with Quest Diagnostics, Abbott Molecular, Pfizer, Bruker and Clarient (see also Health Discovery Corporation ).
"We are extremely fortunate to have attracted someone of John Norris' caliber," said Stephen D. Barnhill, M.D., chairman and CEO of Health Discovery Corporation (HDC). "We expect that his extensive experience and vast relationships in the healthcare space will make a very meaningful contribution to our growth trajectory. John is a visionaryleader who understands how the groundbreaking analytics that we havedeveloped and patented could change the face of diagnostic testing for personalized medicine. His extensive knowledge of the business of healthcare around the world will help us accelerate the commercialization of HDC's new gene-based urine test for prostate cancer."
According to Mr. Norris, "Dr. Barnhill has assembled a world-classteam of researchers, investigators and advisors who have pioneered abold new approach to diagnostics that will vastly improve the speed and accuracy of testing in the realm of gene-based testing, as well as in digital pathology and digital radiology." HDC holds 72 critical patents that are central to the digital convergence of diagnostics, pathology and radiology. "I am very pleased to be part of this outstanding team," Mr. Norris added.
"Our patented Support Vector Machine and Recursive Feature Elimination pattern recognition technologies have been independently validated by top researchers, academics and business professionals around the world and published in dozens of peer-reviewed medical and scientific journals and have broad applicability wherever highly accurate conclusions must be drawn from vast amounts of complex data," Dr. Barnhill said.
Dr. Barnhill continued, "In addition, we expect that John will be a huge asset in promoting our gene-based test for clinically significant prostate cancer recently licensed for commercialization to Abbott, Quest Diagnostics, and Clarient. Right now, half a million men a year in the United States alone have painful, expensive but unnecessarybiopsies for prostate cancer based solely on PSA findings, the current world standard for prostate cancer screening. The previously-announced results of our forthcoming urine-based test for prostate cancer could eliminate many of these unnecessary biopsies and unnecessary treatments such as radical prostate surgery stemming from false positive readings on the PSA test."


PATENTS
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6,944,602.PN.&OS=PN/6,944,602&RS=PN/6,944,602

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=health+discovery&FIELD1=&co1=AND&TERM2=&FIELD2=&d=PTXT


Prostate Cancer Quotes




Insight DX Test



http://www.urotoday.com/index.php?option=com_uij&view=single&issnum=8&volnum=2§ionid=27&Itemid=3369


Urology 1




Leukemia Test


BPH Test


CRC Test


AIDS Test

VIDEOS

 

This is by "Isabella Guyon" who is one of the primary inventors of many asspects that Dr. Barnhill is and has worked with, enjoy and try to listen to this self run teaching for say 15-20 minutes.

http://videolectures.net/bootcamp07_guyon_itml/

Here is our gifted "Bernhard Scholkopf" giving his lecture about machine learning, learning with kernels, mind you this is probably the 10th year of summer school lecture and it isn't summer school for dummies basically for PDd's etc
http://videolectures.net/mlss07_scholkopf_intkmet/

 

Health Discovery Corporation Intellectual Property

Patent Office & Number

Description

U.S. Patent No. 6,128,608

Enhancing Knowledge Discovery Using Multiple Support Vector Machines

U.S. Patent No. 6,157,921

Enhancing Knowledge Discovery Using Support Vector Machines in a Distributed Network Environment

U.S. Patent No. 6,427,141

Enhancing Knowledge Discovery Using Multiple Support Vector Machines.

U.S. Patent No. 6,658,395

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines.

U.S. Patent No. 6,714,925

System for Identifying Patterns in Biological Data Using a Distributed Network.

U.S. Patent No. 6,760,715

Enhancing Biological Knowledge Discovery Using Multiple Support Vector Machines.

U.S. Patent No. 6,789,069

Method of Identifying Patterns in Biological Systems and Method of Uses.

U.S. Patent No. 6,882,990

Method of Identifying Biological Patterns Using Multiple Data Sets.

U.S. Patent No. 6,944,602

Spectral Kernels for Learning Machines

U.S. Patent No. 6,996,542

Computer-Aided Image Analysis

U.S. Patent No. 7,117,188

Methods of Identifying Patterns in Biological Systems and Uses Thereof

U.S. Patent No. 7,299,213

Method of Using Kernel Alignment to Extract Significant Features from a Large Dataset

U.S. Patent No. 7,318,051

Methods for Feature Selection in a Learning Machine

U.S. Patent No. 7,353,215

Kernels and Methods for Selecting Kernels for Use in a Learning Machine

U.S. Patent No. 7,383,237

Computer-Aided Image Analysis

U.S. Patent No. 7,444,308

Data Mining Platform for Bioinformatics and Other Knowledge Discovery

U.S. Patent No. 7,475,048

Pre-Processed Feature Ranking for a Support Vector Machine

U.S. Patent No. 7,542,947

Data Mining Platform for Bioinformatics and Other Knowledge Discovery

U.S. Patent No. 7,542,959

Feature Selection Using Support Vector Machine Classifier

U.S. Patent No.  7,617,163

Kernels and Kernel Methods for Spectral Data

U.S. Patent No. 7,624,074

Methods for Feature Selection in a Learning Machine

Australian Patent No. 764897

Pre-processing and Post-processing for Enhancing Knowledge Discovery Using Support Vector Machines.

Indian Patent No. 212978

Pre-Processing and Post-Processing for Enhancing Knowledge Discovery Using Support Vector Machines

South African Patent No. 00/7122

Pre-processing and Post-processing for Enhancing Knowledge Discovery Using Support Vector Machines.

Australian Patent No. 780050

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines

Chinese Patent No. ZL00808062.3

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines.

European Patent No. 1192595

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines.

German Patent No. DE60024452.0-08

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines.

Indian Patent No. 223409

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines

Israeli Patent No. 146705

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines

Norwegian Patent No. 319,838

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines.

South Korean Patent No. 724104

Enhancing Knowledge Discovery from Data Sets Using Multiple Support Vector Machines

Australian Patent No. 779635

Method of Identifying Patterns in Biological Systems and Method of Uses.

Australian Patent No. 2002243783

Computer Aided Image Analysis

European Patent No. 1356421

Computer Aided Image Analysis

Japanese Patent No. 3947109

Computer Aided Image Analysis

Australian Patent No. 2002253879

Methods of Identifying Patterns in Biological Systems and Uses Thereof

Japanese Patent No. 4138486

Methods of Identifying Patterns in Biological Systems and Uses Thereof

Canadian Application No. 2,330,878

Pre-Processing and Post-Processing for Enhancing Knowledge Discovery Using Support Vector Machines

European Publication No. 1082646

Pre-Processing and Post-Processing for Enhancing Knowledge Discovery Using Support Vector Machines

Hong Kong Application No. 011065063

Pre-Processing and Post-Processing for Enhancing Knowledge Discovery Using Support Vector Machines

Canadian Application No. 2,371,240

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines

Japanese Application No. 2000-620577

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines

Canadian Application No. 2,388,595

Method of Identifying Patterns in Biological Systems and Method of Uses

European Publication No. 1236173

Method of Identifying Patterns in Biological Systems and Method of Uses

Japanese Application No. 2001-534088

Method of Identifying Patterns in Biological Systems and Methods of Uses

U.S. Patent Publication No. 2005/0165556

Colon Cancer-Specific Markers

U.S. Patent Publication No. 2008/0059392

System for Providing Data Analysis Services Using a Support Vector Machine for Processing Data Received from a Remote Source

European Publication No. 1828917

Biomarkers for Screening, Predicting, and Monitoring Prostate Disease

Canadian Application No. 2,435,254

Methods of Identifying Patterns in Biological Systems and Uses Thereof

European Publication No. 1459235

Methods of Identifying Patterns in Biological Systems and Uses Thereof

U.S. Patent Publication No. 2008/0301070

Kernels and Methods for Selecting Kernels for Use in a Learning Machine

Canadian Application No. 2,435,290

Computer Aided Image Analysis

U.S. Patent Publication No. 2008/0140592

Model Selection for Cluster Data Analysis

U.S. Patent Publication No. 2008/0097938

Data Mining Platform for Knowledge Discovery from Heterogeneous Data Types and/or Heterogeneous Data Sources

U.S. Patent Publication No. 2008/0097940

Kernels and Kernel Methods for Spectral Data

U.S. Application No. 12/700,575

Support Vector Machine-Based Method for Analysis of Spectral Data

U.S. Patent Publication No. 2008/0233576

Pre-Processed Feature Ranking for a Support Vector Machine

European Publication No. 1449108

Pre-Processed Feature Ranking for a Support Vector Machine

U.S. Patent Publication No. 2008/0050836

Biomarkers for Screening, Predicting, and Monitoring Benign Prostate Hyperplasia

European Publication No. 1828917

Biomarkers for Screening, Predicting, and Monitoring Prostate Disease

U.S. Patent Publication No. 2009/0215024

Biomarkers Upregulated in Prostate Cancer

U.S. Patent Publication No. 2009/0286240

Biomarkers Overexpressed in Prostate Cancer

U.S. Patent Publication No. 2009/0215058

Methods for Screening, Predicting and Monitoring Prostate Cancer

U.S. Patent Publication No. 2009/0226915

Methods for Screening, Predicting and Monitoring Prostate Cancer

PCT Application No. US2009/66873

Methods for Screening, Predicting and Monitoring Prostate Cancer

U.S. Patent Publication No. 2009/0305257

Biomarkers Downregulated in Prostate Cancer

U.S. Patent Publication No. 2009/0204557

Method and System for Analysis of Flow Cytometry Data Using Support Vector Machines

PCT Publication No.

WO 2009/100410

Method and System for Analysis of Flow Cytometry Data Using Support Vector Machines

U.S. Provisional Application No. 61/289,372

Remote Melanoma Diagnosis Using a Smart Phone

U.S. Provisional Application No. 61/293,987

System and Method for Remote Melanoma Screening Using a Smart Phone

U.S. Provisional Application No. 61/304,796

System and Method for Remote Melanoma Screening

FGM Patents and Applications:

U.S. Patent No. 6,920,451

Method for the Manipulation, Storage, Modeling, Visualization and Quantification of Datasets.

U.S. Patent No. 7,366,719

Method for the Manipulation, Storage, Modeling, Visualization and Quantification of Datasets

European Patent No.: 1252588

Method for the Manipulation, Storage, Modeling, Visualization and Quantification of Datasets.

 



Health Discovery Corporation
2 East Bryan Street, Suite 601
Savannah, Georgia 31401

Phone: 912.443.1987
912.443.1988
Fax: 912.443.1989
Thomas L. Gallagher: President, Chief Operating Officer and General Counsel

investor@healthdiscoverycorp.com

 


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
HDVY
Current Price
Volume:
Bid Ask Day's Range
Wiki
SureTrader
HDVY News: Current Report Filing (8-k) 04/14/2016 03:06:11 PM
HDVY News: Current Report Filing (8-k) 04/05/2016 02:19:46 PM
HDVY News: Annual Report (10-k) 03/30/2016 05:39:03 PM
HDVY News: Quarterly Report (10-q) 11/16/2015 04:44:17 PM
PostSubject
#11076   no worries LocWolf, get some rest. king oil 04/03/16 07:13:43 PM
#11075   some interesting feedback on the new test posted here. king oil 04/03/16 07:09:04 PM
#11074   I need to get back with "King Oil" LocWolf 04/03/16 05:02:20 PM
#11073   NEOLAB PC Test,commercially available, but they won't be Stonemoney 04/03/16 03:12:55 PM
#11072   So now the big question is if this king oil 03/31/16 09:18:20 AM
#11071   I read the yearly filing from yesterday and LocWolf 03/31/16 08:22:22 AM
#11070   I hope all my fellow investors here will LocWolf 03/15/16 02:35:46 PM
#11069   LOL. at least it's still trading, so king oil 03/01/16 01:40:30 PM
#11068   Are you sure? Even zombies tend to walk imperativity 03/01/16 01:32:37 PM
#11067   This stock is a zombie king oil 02/02/16 08:53:46 PM
#11066   It appears little interest for HDVY stock yet LocWolf 01/22/16 05:51:36 PM
#11065   Thin as anything if this volume is getting imperativity 01/21/16 03:14:28 PM
#11064   It looked strange all day. I'm seeing king oil 01/19/16 04:46:56 PM
#11063   Something wrong with this picture???? LocWolf 01/19/16 03:07:53 PM
#11062   thanks, you could very well be correct. king oil 01/19/16 02:28:19 PM
#11061   It seems clear to me that a minimum LocWolf 01/19/16 01:44:28 PM
#11060   Would be good if he could explain how king oil 01/19/16 09:45:55 AM
#11059   Just 3 hours ago, taken from another MB LocWolf 01/17/16 03:27:35 PM
#11058   King, spilled milk - Intel Patents! LocWolf 01/16/16 05:09:16 PM
#11057   I'm not sure what HDVY can do about king oil 01/16/16 01:59:19 PM
#11056   HDVY Management and many of us shareholders don’t LocWolf 01/16/16 01:01:19 PM
#11055   they do that sometimes..i call that the possum diversion Roy London 01/12/16 11:56:42 AM
#11054   looks like it went quiet again. hate king oil 01/12/16 11:48:57 AM
#11053   love to see they have been taking Roy London 01/12/16 07:24:24 AM
#11052   We've got to see increased volume for this spongiformbobsqpants 01/12/16 12:44:16 AM
#11051   give it time Roy London 01/11/16 06:01:25 PM
#11050   Volume is decent. Too bad it didn't hold 7. king oil 01/11/16 04:59:20 PM
#11049   very thin...could see teens here very quickly Roy London 01/11/16 03:07:38 PM
#11048   explosive chart ...Ichimoku weekly breakout Roy London 01/11/16 03:06:08 PM
#11047   level 2's look good too...perhaps CD's are done...must Roy London 01/11/16 03:04:55 PM
#11046   HDVY something is up here 2 years of Roy London 01/11/16 03:03:32 PM
#11045   wow. 7 cents! king oil 01/11/16 02:59:20 PM
#11044   very true. Maybe it's coming soon? king oil 01/11/16 02:10:21 PM
#11043   a lot of CD's... these guys need revenue Roy London 01/10/16 07:02:01 PM
#11042   otc usually does better it that senario Roy London 01/10/16 06:39:45 PM
#11041   Especially nice while the rest of the market king oil 01/10/16 06:24:23 PM
#11040   nice weekly chart...on watch Roy London 01/10/16 04:20:59 PM
#11039   We'll see. I'd like to see million+ share imperativity 01/08/16 04:14:46 PM
#11038   I'm pleasantly surprised. Nice to see this wake imperativity 01/08/16 04:13:55 PM
#11037   Looks like the buying is picking up steam. spongiformbobsqpants 01/08/16 12:24:52 PM
#11036   52wk high today. nice year so far. king oil 01/08/16 12:23:29 PM
#11035   It certainly does. A good new year to imperativity 01/04/16 01:52:15 PM
#11034   thanks very much. Sounds great, let's hope king oil 01/04/16 01:38:14 PM
#11033   Here you go! I still follow this stock imperativity 01/04/16 01:35:14 PM
#11030   Could someone repost it here? king oil 12/28/15 05:44:03 PM
#11029   Check out bill quirk's message on raging bull spongiformbobsqpants 12/28/15 03:13:15 PM
#11028   HDVY shareholders and management have been concerned about LocWolf 12/28/15 01:02:20 PM
#11027   The NeoGenomic Corporation have exhausted their two one LocWolf 12/25/15 10:10:24 PM
#11026   In January we will be in the 5 Stonemoney 12/25/15 02:49:04 PM
#11025   There have been papers filed as early as LocWolf 12/24/15 01:35:40 PM
PostSubject